Innovasis

Tolero Pharmaceuticals, a division of Sumitomo Pharma Oncology, is a leading global developer of innovative cancer therapeutics. Their commitment to purposeful science in oncology drives the development of a diverse and targeted pipeline of therapies. With a focus on novel approaches to cancer treatment, Tolero Pharmaceuticals is dedicated to advancing the promise of precision medicine in the fight against cancer. Learn more about their impactful contributions to the field of oncology. Generated from their website's infomation

Physicians Research Options (PRO) is an experienced Clinical Research Company specializing in Phase II, III, and IV Pharmaceutical and Pilot Pivotal Medical Device clinical trials. With over 60 years of combined staff experience, PRO operates in five investigative clinics in Utah and Colorado, offering comprehensive services for sponsor companies and maintaining affiliations with local physicians and medical facilities. PRO's dedicated team of Clinical Investigators and staff are committed to providing high-quality patient care and study data. Located in modern medical-office complexes near the Wasatch Mountains, PRO conducts a range of trials and is equipped to support various medical device clinical research endeavors, ensuring quality and efficiency in all phases of clinical trials.Generated from the website